TP53 Arg72Pro polymorphism and its relationship with major depressive disorder

Polimorfismo TP53 Arg72Pro e sua relação com o transtorno depressivo maior

Autores

Palavras-chave:

Depressive Disorder, Major, Polymorphism, Genetic, Tumor Suppressor Protein p53

Resumo

This study investigates the association between the TP53 Arg72Pro polymorphism and major depressive disorder (MDD) using a case-control approach. The study sample comprised 97 individuals: 16 in the case group diagnosed with MDD and 81 in the control group. Genotyping was conducted using the PCR-RFLP technique, with the genotypic frequencies calculated by direct counting and statistical significance at 5% (P<0.05). Results indicated that the TP53 Arg72Pro polymorphism's Pro allele was significantly more frequent in the MDD case group. These findings suggest that the Pro allele is associated with an increased risk of developing major depressive disorder.

Downloads

Não há dados estatísticos.

Referências

ALI, Hamida et al. PCR-RFLP genotyping analysis of TP53 Arg72Pro polymorphism and susceptibility to esophageal cancer in Pakistani population. Gene Reports, v. 25, p. 101406, 2021.https://doi.org/10.1016/j.genrep.2021.101406

AMERICAN PSYCHIATRIC ASSOCIATION et al. DSM-5: Manual diagnóstico e estatístico de transtornos mentais. 5.ed. Porto Alegre: Artmed Editora, 2014.

ARANTES-GONÇALVES, Filipe; COELHO, Rui. Depressão e tratamento. Apoptose, neuroplasticidade e antidepressivos. Acta Médica Portuguesa, v. 19, n. 1, p. 9-20, 2006. https://doi.org/10.20344/amp.910

DROKOW, Emmanuel Kwateng et al. The relationship between leukemia and TP53 gene codon Arg72Pro polymorphism: analysis in a multi-ethnic population. Future Oncology, v. 16, n. 14, p. 923-937, 2020. https://doi.org/10.2217/fon-2019-0792

DYGALO, Nikolay N. et al. Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior. Cellular and molecular neurobiology, v. 32, p. 767-776, 2012. https://doi.org/10.1007/s10571-011-9794-y

GOMES, Joyce de Pontes; GASPAR, Danielle Macêdo. A origem da depressão: Teorias sobre o desconhecido. IV simpósio de pesquisa em ciências médicas, 2018.

HARA, Makoto R. et al. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. Nature, v. 477, n. 7364, p. 349-353, 2011. https://doi.org/10.1038/nature10368

HU, Jiahao et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. Journal of hematology & oncology, v. 14, p. 1-19, 2021. https://doi.org/10.1186/s13045-021-01169-0.

MOISAN, Marie-Pierre et al. Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission. Translational Psychiatry, v. 11, n. 1, p. 203, 2021. https://doi.org/10.1038/s41398-021-01323-9

NAKANO, Shiori et al. p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study. Cancer Science, v. 113, n. 12, p. 4385-4393, 2022. https://doi.org/10.1111/cas.15572

OTTE, Christian et al. Major depressive disorder. Nature reviews Disease primers, v. 2, n. 1, p. 1-20, 2016. https://doi.org/10.1038/nrdp.2016.65

PUNJA, Harshitha K. et al. TP53 codon 72 polymorphism and type 2 diabetes: a case–control study in South Indian population. Molecular Biology Reports, v. 48, n. 6, p. 5093-5097, 2021. https://doi.org/10.1007/s11033-021-06505-8

RĂDULESCU, Ioana et al. Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy. Experimental and therapeutic medicine, v. 22, n. 4, p. 1-8, 2021. https://doi.org/10.3892/etm.2021.10565

SANTOS, Patrícia Ferreira da Costa Ramos dos. Neuroinflamação e a depressão: novas abordagens terapêuticas no horizonte?. 2019. http://hdl.handle.net/10451/43547

SŁOMIŃSKI, Bartosz et al. Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes. Journal of Molecular Medicine, v. 99, p. 675-683, 2021. https://doi.org/10.1007/s00109-020-02035-1

SULLIVAN, Patrick F.; NEALE, Michael C.; KENDLER, Kenneth S. Genetic epidemiology of major depression: review and meta-analysis. American journal of psychiatry, v. 157, n. 10, p. 1552-1562, 2000. https://doi.org/10.1176/appi.ajp.157.10.1552

WORLD HEALTH ORGANIZATION. World mental health report: Transforming mental health for all. 2022. Disponível em: https://www.who.int/teams/mental-health-and-substance-use/world-mental-health-report. Acesso em: 28 mai. 2023.

YEO, In Jun et al. p53 Knock Out Mice Enhances Anxiety-and Depression-Like Behaviors through an Increase of Glutamate, Calcium, and Cytokine-Mediated Cell Death Signals. 2021. https://doi.org/10.21203/rs.3.rs-929317/v1

Downloads

Publicado

2024-07-23

Como Citar

Rodrigues, G. O. ., Sousa Silva Bonasser, L., de Lima Santos, M., Ferreira Fratelli, C., Maria de Souza Silva, C., & Cristina Rodrigues da Silva, I. (2024). TP53 Arg72Pro polymorphism and its relationship with major depressive disorder : Polimorfismo TP53 Arg72Pro e sua relação com o transtorno depressivo maior. Concilium, 24(14), 214–223. Recuperado de http://clium.org/index.php/edicoes/article/view/3726

Edição

Seção

Articles